高龄前列腺增生患者行经尿道2 μm激光气化切除术的疗效与安全性

Efficacy and safety of RevoLix 2 micron continuous wave laser vaporesection in treatment for senile patients with benign prostatic hyperplasia

回顾性分析2010年7月至2014年7月213例行经尿道2 μm激光前列腺气化切除术（激光组）和78例行经尿道前列腺电切术治疗前列腺增生患者（电切组）的临床资料.患者年龄70-89岁.激光组与电切组相比在手术出血量、术后冲洗时间,带管时间及住院时间等有一定优势,激光组围手术期并发症明显减少.激光组总体主客观各项指标在术后3、12个月时均较术前有明显改善;70-79岁者的国际前列腺症状评分（IPSS）总分、储尿期IPSS症状评分（IPSS-S）和膀胱过度活动症状评分改善方面均优于≥ 80岁者,提示年龄是手术后储尿期症状改善的重要因素.中重度膀胱过度活动（OAB）者的IPSS总分、IPSS-S的改善均优于轻度OAB者,提示手术充分解除梗阻后也可以明显改善储尿期症状.

The clinical efficacy and safety of RevoLix 2 μm continuous wave laser vaporesection in treatment of senile patients with benign prostatic hyperplasia （BPH） were retrospective evaluated.In 291 senile patients with BPH,213 received 2 μm continuous wave laser vaporesection （group A） and other 78 patients received transurethral resection of prostate （TURP, group B）.Compared with group B the intraoperative blood loss was less, the bladder irrigation time, catheter time and hospitalization time were shorter in group A.The subjective or objective indexes were all significantly improved at 3 and 12 months after laser treatment.The improvements of international prostate symptom score （IPSS）, IPSS-S, overactive bladder symptom score （OABSS） in patients of 70-79 were more marked than those of 80 or older.Patients with mild overactive bladder （OAB） had less improvement in IPSS and IPSS-S than those with moderate-severe OAB which suggest that the storage symptoms could be improved significantly by removing obstruction.